These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9291932)

  • 21. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.
    Meyer L; Magierowska M; Hubert JB; Rouzioux C; Deveau C; Sanson F; Debre P; Delfraissy JF; Theodorou I
    AIDS; 1997 Sep; 11(11):F73-8. PubMed ID: 9302436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to HIV infection: the genes are only part of the solution.
    Clerici M; Clivio A; Shearer GM
    Trends Microbiol; 1997 Jan; 5(1):2-4. PubMed ID: 9025227
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV CCR5 resistance incomplete.
    Smith O
    Nat Med; 1997 Apr; 3(4):372-3. PubMed ID: 9095162
    [No Abstract]   [Full Text] [Related]  

  • 24. Possible influence of the mutant CCR5 Allele on vertical transmission of HIV-1.
    Mandl CW; Aberle SW; Henkel JH; Puchhammer-Stöckl E; Heinz FX
    J Med Virol; 1998 May; 55(1):51-5. PubMed ID: 9580886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.
    Kamkamidze G; Capoulade-Metay C; Butsashvili M; Dudoit Y; Chubinishvili O; Debre P; Theodorou L
    Georgian Med News; 2005 Jan; (118):74-9. PubMed ID: 15821335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants.
    Villalba N; Pérez-Olmeda M; de José M; Hernández M; Sirera R; Español T; González-Molina A; Soriano V
    Eur J Clin Microbiol Infect Dis; 1999 May; 18(5):389-91. PubMed ID: 10421054
    [No Abstract]   [Full Text] [Related]  

  • 27. Intact CCR-5 coreceptors in HIV-1-infected chimpanzees.
    ten Haaft PJ; Murthy KK; Verstrepen BE; Eichberg JW; Heeney JL
    AIDS; 1997 Aug; 11(10):1291-3. PubMed ID: 9256948
    [No Abstract]   [Full Text] [Related]  

  • 28. CC-chemokine receptor 5 genotypes and in vitro susceptibility to HIV-1 of a cohort of British HIV-exposed uninfected homosexual men.
    Aarons E; Fernandez M; Rees A; McClure M; Weber J
    AIDS; 1997 Apr; 11(5):688-9. PubMed ID: 9108955
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of protection from HIV infection by the mutant HIV coreceptor CCR5 in intravenously HIV infected hemophilia patients.
    Malo A; Rommel F; Bogner J; Gruber R; Schramm W; Goebel FD; Riethmüller G; Wank R
    Immunobiology; 1998 Feb; 198(4):485-8. PubMed ID: 9562872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new CX3 CR1 genotype with implications for HIV disease progression.
    Roman F; Deroo S; Franck N; Burgy C; Servais J; Schmit JC
    AIDS; 2001 Mar; 15(5):659-60. PubMed ID: 11317010
    [No Abstract]   [Full Text] [Related]  

  • 31. CCR5 promoter polymorphisms and HIV-1 perinatal transmission in Brazilian children.
    de Souza PR; Arraes LC; de Lima Filho JL; Bruneska D; Milanese M; Crovella S
    J Reprod Immunol; 2006 Feb; 69(1):77-84. PubMed ID: 16233918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCR5, vertical transmission of HIV-1, and disease progression. European Collaborative Study.
    Bailey AJ; Newell ML; De Rossi A; Giaquinto C; Iasci A; Ravizza M; Garcia-Rodriguez MC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):211-2. PubMed ID: 10048913
    [No Abstract]   [Full Text] [Related]  

  • 33. The extent of genetic variation in the CCR5 gene.
    Ansari-Lari MA; Liu XM; Metzker ML; Rut AR; Gibbs RA
    Nat Genet; 1997 Jul; 16(3):221-2. PubMed ID: 9207783
    [No Abstract]   [Full Text] [Related]  

  • 34. Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus.
    Mangano A; Gonzalez E; Dhanda R; Catano G; Bamshad M; Bock A; Duggirala R; Williams K; Mummidi S; Clark RA; Ahuja SS; Dolan MJ; Bologna R; Sen L; Ahuja SK
    J Infect Dis; 2001 Jun; 183(11):1574-85. PubMed ID: 11335892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV experts vs. sequencers in patent race.
    Marshall E
    Science; 1997 Feb; 275(5304):1263. PubMed ID: 9064781
    [No Abstract]   [Full Text] [Related]  

  • 36. Distribution of CCR-5 delta32 allele in Argentinian children at risk of HIV-1 infection: its role in vertical transmission.
    Mangano A; Prada F; Roldán A; Picchio G; Bologna R; Sen L
    AIDS; 1998 Jan; 12(1):109-10. PubMed ID: 9456261
    [No Abstract]   [Full Text] [Related]  

  • 37. Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry.
    Doms RW; Peiper SC
    Virology; 1997 Sep; 235(2):179-90. PubMed ID: 9281497
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of CCR5 chemokine receptor gene in vertical human immunodeficiency virus type 1 transmission and disease progression.
    Esposito S; Zehender G; Zuccotti GV; Vegni C; Galli L; Vecchi V; Agostoni C; Rancilio L; De Maddalena C; Clerici M; Principi N
    Pediatr Infect Dis J; 1998 Sep; 17(9):847-9. PubMed ID: 9779780
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands.
    Arenzana-Seisdedos F; Parmentier M
    Semin Immunol; 2006 Dec; 18(6):387-403. PubMed ID: 16978874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.
    Ometto L; Bertorelle R; Mainardi M; Zanchetta M; Tognazzo S; Rampon O; Ruga E; Chieco-Bianchi L; De Rossi A
    J Infect Dis; 2001 Mar; 183(5):814-8. PubMed ID: 11181160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.